-+ 0.00%
-+ 0.00%
-+ 0.00%

Keros Therapeutics announces annual shareholder meeting notice

PUBT·04/22/2026 20:03:14
Listen to the news
Keros Therapeutics announces annual shareholder meeting notice
  • Keros Therapeutics schedules 2026 annual stockholder meeting in virtual format on June 3, 2026.
  • Votes will cover election of two Class III directors: Jean-Jacques Bienaimé, Charles Newton.
  • Shareholders will also vote on ratification of Deloitte & Touche as independent registered public accounting firm for fiscal year ending Dec. 31, 2026.
  • Meeting agenda includes advisory vote on compensation for named executive officers.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Keros Therapeutics Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-046791), on April 22, 2026, and is solely responsible for the information contained therein.